Liver disease and confusion: does albumin level matter?
Part of Brain & nervous system, Digestive system, Hormones & metabolism clinical trials.
This study looks at whether low albumin levels in the blood are linked to more severe confusion caused by liver disease. It may help doctors understand how to better manage hepatic encephalopathy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old.
- You have been diagnosed with chronic liver disease (confirmed by imaging and blood tests).
- You have had episodes of confusion or altered mental state due to liver disease (hepatic encephalopathy).
- You are able to understand and sign a consent form.
- You do not have acute liver failure, kidney failure on dialysis, active cancer, or be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with hepatic encephalopathy (a condition that causes confusion due to liver problems) engage with their care. It is for adults who have not yet been treated for the condition.
This study is creating a new test to measure thinking and memory problems in people with liver cirrhosis. It may help doctors find these problems earlier.
This study tests whether taking extra protein in the late evening or early morning can lower the chance of being readmitted for hepatic encephalopathy, a brain problem that can happen with liver disease. It may help by supporting safer nutrition and reducing the risk of another hospitalization.
This trial tests whether giving human albumin through a vein can help people with liver cirrhosis who have confusion or drowsiness from a condition called hepatic encephalopathy. It is for patients with low albumin levels.
This study looks at how well two factors—a score called ALBI (a measure of liver function) and muscle wasting (sarcopenia)—can predict outcomes in people with cirrhosis who are hospitalized for confusion from liver disease. The goal is to see if these markers can help doctors better understand recovery and risks.
This study is looking at whether changes in a protein called albumin can help find liver disease earlier. It is for people who have some liver scarring but no serious complications.
Hear when a new Hepatic Encephalopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.